What is the average price target for MEDIFAST INC (MED) stock?
9 analysts have analysed MED and the average price target is 12.24 USD. This implies a price increase of 21.73% is expected in the next year compared to the current price of 10.055.
MEDIFAST INC (MED) Forecast, Price Target & Analyst Ratings
NYSE:MED • US58470H1014
Current stock price
10.055 USD
-0.13 (-1.32%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDIFAST INC (MED).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 27, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.53
- Revenue Estimate
- 69.892M
Price Target Details & History
Consensus Price Target and Range
Mean target
$12.24
Upside
+ 21.73%
From current price of $10.06 to mean target of $12.24, Based on 9 analyst forecasts
Low
$12.12
Median
$12.24
High
$12.60
Price Target Revisions
1 Month
0.00%
3 Months
-20.00%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for MED. The average price target is 12.24 USD. This implies a price increase of 21.73% is expected in the next year compared to the current price of 10.055.
The average price target has been revised downward by 20% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
46.67%
MED was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about MED.
In the previous month the buy percentage consensus was at a similar level.
MED was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-19 | Stephens & Co. | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-19 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-11-05 | DA Davidson | Upgrade | Underperform -> Neutral |
| 2024-07-22 | DA Davidson | Maintains | Underperform -> Underperform |
| 2024-06-05 | DA Davidson | Downgrade | Neutral -> Underperform |
| 2024-04-30 | DA Davidson | Maintains | Neutral -> Neutral |
| 2024-02-21 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-10-13 | Stephens & Co. | Initiate | Equal-Weight |
| 2023-08-08 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-07-31 | DA Davidson | Maintains | Neutral -> Neutral |
| 2023-05-02 | DA Davidson | Maintains | Neutral |
| 2023-02-22 | DA Davidson | Maintains | Neutral |
| 2022-11-04 | DA Davidson | Downgrade | Buy -> Neutral |
| 2022-08-04 | DA Davidson | Maintains | Buy |
| 2022-08-04 | Jefferies | Downgrade | Buy -> Hold |
| 2022-06-02 | DA Davidson | Maintains | Buy |
| 2022-02-24 | DA Davidson | Maintains | Buy |
| 2021-11-08 | DA Davidson | Maintains | Buy |
| 2021-05-05 | DA Davidson | Maintains | Buy |
| 2021-02-26 | DA Davidson | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 27, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.53
- Revenue Estimate
- 69.892M
- Revenue Q2Q
- -39.61%
- EPS Q2Q
- -377.45%
- Number of Analysts
- 2
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
-24.21%
EPS (1 Month)
0.00%
EPS (3 Months)
-44.44%
Next Earnings Summary
MED is expected to report earnings on 4/27/2026. The consensus EPS estimate for the next earnings is -0.53 USD and the consensus revenue estimate is 69.89M USD.
The next earnings revenue estimate has been revised downward by 24.21% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates 2026 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.072B -32.94% | 602.463M -43.80% | 385.788M -35.96% | 276.44M -28.34% | 249.87M -9.61% | |
| EBITDA YoY % growth | 139.509M -28.75% | 32.176M -76.94% | 29K -99.91% | -4.545M -15,772.41% | -13.332M -193.33% | |
| EBIT YoY % growth | 126.402M -31.60% | 19.469M -84.60% | -14.213M -173.00% | -24.644M -73.39% | -33.128M -34.43% | |
| Operating Margin | 11.79% | 3.23% | -3.68% | -8.91% | -13.26% | |
| EPS YoY % growth | 9.11 -32.77% | 2.03 -77.72% | -1.75 -186.21% | -2.00 -14.27% | -2.79 -39.39% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.53 -377.45% | -0.43 -297.41% | -0.38 -82.76% | -0.66 60.21% | -0.66 -25.00% | -0.64 -46.51% | -0.62 -60.53% | -0.88 -33.85% |
| Revenue Q2Q % growth | 69.892M -39.61% | 75.447M -28.52% | 68.377M -23.52% | 62.62M -16.61% | 59.186M -15.32% | 67.064M -11.11% | 62.923M -7.98% | 60.6M -3.23% |
| EBITDA Q2Q % growth | -2.02M -242.45% | 707K -88.70% | -808K -112.07% | -2.424M -137.65% | -3.636M -80.00% | -1.717M -342.86% | -3.333M -312.50% | -4.646M -91.67% |
| EBIT Q2Q % growth | -6.262M -236.31% | -5.555M -421.11% | -4.949M -21.27% | -7.979M -2.26% | -7.777M -24.19% | -7.676M -38.18% | -7.373M -48.98% | -10.302M -29.11% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
MEDIFAST INC / MED Forecast FAQ
Can you provide the upcoming earnings date for MEDIFAST INC?
MEDIFAST INC (MED) will report earnings on 2026-04-27.
What are the consensus estimates for MEDIFAST INC (MED) next earnings?
The consensus EPS estimate for the next earnings of MEDIFAST INC (MED) is -0.53 USD and the consensus revenue estimate is 69.89M USD.